PermeaDerm accelerates early wound healing in partial-thickness burns: A multicenter randomized controlled trial.
Hongtai Tang, Guoping Chu, Jun Xiang et al.
✦ AI-curated · Sources linked
In 30 seconds
This multicenter randomized controlled trial assessed the efficacy of PermeaDerm, a biosynthetic wound matrix, versus porcine acellular dermal matrix (ADM) in 184 Chinese patients with partial-thickness burns. PermeaDerm demonstrated superior early complete re-epithelialization rates at day 7 for both superficial (55.6% vs. 27.0%) and deep burns (37.2% vs. 12.7%), indicating its potential as an effective treatment option.
Key findings
- At day 7, 55.6% of superficial burns treated with PermeaDerm achieved complete re-epithelialization compared to 27.0% with ADM.
- For deep partial-thickness burns, 37.2% of wounds treated with PermeaDerm achieved complete re-epithelialization at day 7 versus 12.7% with ADM.
- The median wound area reduction rate at day 7 was significantly higher with PermeaDerm for both burn types.
- Median time to complete re-epithelialization was 3 days shorter with PermeaDerm for both superficial and deep burns.
Why it matters
The findings suggest that PermeaDerm can significantly enhance early wound healing in partial-thickness burns, which may lead to improved patient outcomes and satisfaction. Understanding effective treatment options is crucial for optimizing care in burn management.